TerraCycle appoints former AstraZeneca, Phibro Animal Health exec as new CFO

Damian Finio to succeed Javier Daly

Trenton-based TerraCycle on Wednesday announced that Damian Finio will join the company’s global leadership team as chief financial officer, effective Oct. 2.

Finio most recently served as CFO of Phibro Animal Health Corp., and joins TerraCycle with more than 30 years of financial management experience, primarily in the life sciences industry, having spent nearly half of his career at AstraZeneca.

Finio will succeed TerraCycle’s current CFO, Javier Daly, who will retire in early 2024. During his 13-year tenure, Daly is credited with driving the organization to profitability, building a solid foundation of financial systems and processes needed to support the organization’s diverse business models, and furthering innovation in recycling and reuse.

Finio holds a Bachelor of Science in accounting and an MBA. Although now inactive, he was also a Certified Public Accountant and Certified Treasury Professional earlier in his career.

“Finio’s wealth of experience will be a valuable asset as we continue to explore options to fuel our plans for continued growth,” TerraCycle founder and CEO Tom Szaky said. “I value his passion for our work and his desire to use his vast skills to contribute to our mission, impact and financial success.”

“TerraCycle is a high-momentum company on a mission to solve today’s complex waste challenges. I’m looking forward to working closely with TerraCycle’s global leadership team to unlock new ways to drive its global growth and impact,” Finio said.

With revenues growing consistently each year, TerraCycle is an award-winning private company operating in recycling hard-to-recycle waste and circular innovation since 2003.